Skip to main content
. 2021 Aug 5;59:339–350. doi: 10.1016/j.breast.2021.07.019

Fig. 2.

Fig. 2

HER2-dependent pathway for proliferation and survival in HER2+ breast cancer.Legend. cHER2+: clinically HER2-positive; HER2-E: HER2-Enriched. The red cone visually suggests a higher activation of the HER2-related pathway in cHER2+/HER2-E tumors, compared to cHER2+/non-HER2-E.